ArticleInvestigational new drugs2020

Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling.

Lei Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.